Wave Life Sciences Files Q1 2025 10-Q

TL;DR

WAVE Q1 2025 10-Q filed. Financials and operations update.

AI Summary

Wave Life Sciences Ltd. filed its 10-Q for the period ending March 31, 2025. The company's business address is in Singapore, with a mailing address in Cambridge, MA. Key dates mentioned include the filing date of May 8, 2025, and the reporting period from January 1, 2025, to March 31, 2025.

Why It Matters

This filing provides investors with an update on Wave Life Sciences' financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a life sciences company, Wave Life Sciences is subject to inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

• 20250331 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
• 20250508 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

• Wave Life Sciences Ltd. (company) — Filer of the 10-Q
• 20250331 (date) — End of the reporting period
• 20250508 (date) — Filing date
• 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER, SINGAPORE 018936 (address) — Business address
• 733 CONCORD AVENUE, CAMBRIDGE, MA 02138 (address) — Mail address
• GSKEquityInvestment (event) — Mentioned in relation to an equity investment
• GregoryVerdine (person) — Mentioned in relation to the company
• AikNaTan (person) — Mentioned in relation to the company
• HeidiWagner (person) — Mentioned in relation to the company

FAQ

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 by GregoryVerdine regarding Wave Life Sciences Ltd. (WVE).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR